TMPRSS2 and prostate adenocarcinoma: The most altered genes in this complex also significantly distinguished TMPRSS2 fusion positive from negative tumors in TCGA-PRAD cohort (χ2P = 0.002), suggesting that genomic ancestry impacted expression of these genes was most common in the absence of TMPRSS2 fusion (Supplementary Fig. S11C).